This is a non-core endpoint: only basic statistics are computed.
Afelimomab
RX_L04AB03
No definition available.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
Medicine purchases: ATC
L04AB03
1 out of 7 registries used, show all original rules.
0
Check minimum number of events
Min. number of events
3
0
Include endpoints None
0
Remove individuals based on genotype QC
-
RX_L04AB03
Control definitions
Control exclude
RX_L04AB
Extra metadata
First used in FinnGen datafreeze
DF4
No data for upset plot.
No data for upset table.
Similar endpoints
↥List of similar endpoints to
Afelimomab
based on the number of shared cases.
Broader endpoints:
None
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | - | - | - |
| Unadjusted prevalence (%) | - | - | - |
| Mean age at first event (years) | - | - | - |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: RX_L04AB03 – Afelimomab
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Afelimomab
↥Endpoint not on priority list, no data to show.